Not applicableAvailableNCT04837703
What this trial is testing
MAP to Provide Access to Eltrombopag, for Treatment of Patients With Medically Significant Thrombocytopenia
Who this might be right for
Thrombocytopenia
Novartis Pharmaceuticals
Showing 5 of 5 results